|
Basic Characteristics of Mutations
|
|
Mutation Site
|
T766A |
|
Mutation Site Sentence
|
Table 2 |
|
Mutation Level
|
Nucleotide level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
RT |
|
Standardized Encoding Gene
|
P
|
|
Genotype/Subtype
|
C |
|
Viral Reference
|
EU871982.1
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Carcinoma, Hepatocellular
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
China |
|
Literature Information
|
|
PMID
|
24788140
|
|
Title
|
Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma
|
|
Author
|
Wu Y,Gan Y,Gao F,Zhao Z,Jin Y,Zhu Y,Sun Z,Wu H,Chen T,Wang J,Sun Y,Fan C,Xiang Y,Qian G,Groopman JD,Gu J,Tu H
|
|
Journal
|
PloS one
|
|
Journal Info
|
2014 May 1;9(5):e94864
|
|
Abstract
|
BACKGROUND/AIM: Hepatitis B Virus (HBV) mutations play a role in the development of hepatocellular carcinoma (HCC). However, the association between HBV polymerase gene mutations and HCC has not been reported. In this study, we conducted a multi-stage study to identify HCC-related mutations in the reverse transcriptase (RT) domain of the HBV polymerase gene. METHODS: A total of 231 HCCs and 237 non-HCC controls from Qidong, China, were included in this study. The entire sequence of HBV RT was first compared between 29 HCC and 35 non-HCC cases, and candidate mutations were then evaluated in two independent validation sets. RESULTS: There were 15 candidate mutations identified from the discovery set, with A799G and T1055A being consistently associated with HCC across all studies. A pooled analysis of samples revealed that A799G, A987G, and T1055A were independent risk factors for HCC, with adjusted odds ratios of 5.53 [95% confidence interval (CI), 1.69-18.10], 4.20 (95%CI, 1.15-15.35), and 3.78 (95%CI, 1.45-9.86), respectively. A longitudinal study showed that these mutations were detectable 4-5 years prior to HCC diagnosis. CONCLUSIONS: Our study provides evidence the first that HBV RT contains naturally occurring mutations that can be used as predictive markers for HCC.
|
|
Sequence Data
|
KJ460502-KJ460969
|
|
|